Annual EBITDA
-$191.04 M
-$60.22 M-46.04%
31 December 2023
Summary:
Prothena annual earnings before interest, taxes, depreciation & amortization is currently -$191.04 million, with the most recent change of -$60.22 million (-46.04%) on 31 December 2023. During the last 3 years, it has fallen by -$264.13 million (-361.37%). PRTA annual EBITDA is now -361.37% below its all-time high of $73.09 million, reached on 31 December 2021.PRTA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$66.29 M
-$124.89 M-213.10%
30 September 2024
Summary:
Prothena quarterly earnings before interest, taxes, depreciation & amortization is currently -$66.29 million, with the most recent change of -$124.89 million (-213.10%) on 30 September 2024. Over the past year, it has increased by +$11.95 million (+15.28%). PRTA quarterly EBITDA is now -159.75% below its all-time high of $110.94 million, reached on 30 September 2021.PRTA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$167.23 M
-$76.82 M-84.98%
30 September 2024
Summary:
Prothena TTM earnings before interest, taxes, depreciation & amortization is currently -$167.23 million, with the most recent change of -$76.82 million (-84.98%) on 30 September 2024. Over the past year, it has increased by +$22.88 million (+12.03%). PRTA TTM EBITDA is now -309.36% below its all-time high of $79.88 million, reached on 30 September 2021.PRTA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +15.3% | +12.0% |
| 3 y3 years | -361.4% | -100.3% | -316.9% |
| 5 y5 years | -142.0% | -207.7% | -111.8% |
PRTA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -361.4% | at low | -213.1% | +18.5% | -316.9% | +22.3% |
| 5 y | 5 years | -361.4% | at low | -159.8% | +18.5% | -309.4% | +22.3% |
| alltime | all time | -361.4% | at low | -159.8% | +18.5% | -309.4% | +22.3% |
Prothena EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$66.29 M(-213.1%) | -$167.23 M(+85.0%) |
| June 2024 | - | $58.61 M(-172.1%) | -$90.41 M(-58.0%) |
| Mar 2024 | - | -$81.31 M(+3.9%) | -$215.30 M(+13.2%) |
| Dec 2023 | -$191.04 M(+46.0%) | -$78.24 M(-842.5%) | -$190.11 M(+69.8%) |
| Sept 2023 | - | $10.54 M(-115.9%) | -$111.94 M(-33.4%) |
| June 2023 | - | -$66.28 M(+18.1%) | -$168.16 M(+16.0%) |
| Mar 2023 | - | -$56.12 M(>+9900.0%) | -$144.91 M(+14.5%) |
| Dec 2022 | -$130.81 M(-279.0%) | -$72.00 K(-99.8%) | -$126.54 M(-20.7%) |
| Sept 2022 | - | -$45.68 M(+6.2%) | -$159.56 M(+5321.8%) |
| June 2022 | - | -$43.02 M(+13.9%) | -$2.94 M(-104.2%) |
| Mar 2022 | - | -$37.76 M(+14.1%) | $69.74 M(-9.5%) |
| Dec 2021 | $73.09 M(-165.7%) | -$33.09 M(-129.8%) | $77.09 M(-3.5%) |
| Sept 2021 | - | $110.94 M(+274.1%) | $79.88 M(-232.8%) |
| June 2021 | - | $29.66 M(-197.5%) | -$60.14 M(-47.6%) |
| Mar 2021 | - | -$30.41 M(+0.3%) | -$114.79 M(+6.8%) |
| Dec 2020 | -$111.22 M(+40.9%) | -$30.31 M(+4.2%) | -$107.50 M(+8.9%) |
| Sept 2020 | - | -$29.09 M(+16.4%) | -$98.74 M(+11.1%) |
| June 2020 | - | -$24.99 M(+8.1%) | -$88.91 M(+10.1%) |
| Mar 2020 | - | -$23.12 M(+7.3%) | -$80.72 M(+2.3%) |
| Dec 2019 | -$78.94 M(-47.1%) | -$21.54 M(+11.8%) | -$78.94 M(+1.8%) |
| Sept 2019 | - | -$19.26 M(+14.6%) | -$77.55 M(-3.3%) |
| June 2019 | - | -$16.80 M(-21.2%) | -$80.15 M(-35.1%) |
| Mar 2019 | - | -$21.33 M(+5.9%) | -$123.46 M(-17.3%) |
| Dec 2018 | -$149.20 M | -$20.15 M(-7.9%) | -$149.20 M(-14.7%) |
| Sept 2018 | - | -$21.87 M(-63.6%) | -$174.81 M(-14.9%) |
| June 2018 | - | -$60.11 M(+27.7%) | -$205.35 M(+26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$47.08 M(+2.9%) | -$162.55 M(+7.8%) |
| Dec 2017 | -$150.85 M(-3.1%) | -$45.76 M(-12.7%) | -$150.85 M(-1.0%) |
| Sept 2017 | - | -$52.40 M(+202.6%) | -$152.41 M(+7.5%) |
| June 2017 | - | -$17.32 M(-51.0%) | -$141.77 M(-13.5%) |
| Mar 2017 | - | -$35.37 M(-25.3%) | -$163.96 M(+5.3%) |
| Dec 2016 | -$155.67 M(+96.7%) | -$47.32 M(+13.3%) | -$155.74 M(+17.6%) |
| Sept 2016 | - | -$41.76 M(+5.7%) | -$132.42 M(+17.1%) |
| June 2016 | - | -$39.50 M(+45.5%) | -$113.12 M(+23.7%) |
| Mar 2016 | - | -$27.16 M(+13.2%) | -$91.45 M(+15.6%) |
| Dec 2015 | -$79.13 M(+1239.8%) | -$23.99 M(+6.8%) | -$79.13 M(+16.3%) |
| Sept 2015 | - | -$22.46 M(+25.9%) | -$68.05 M(+16.3%) |
| June 2015 | - | -$17.84 M(+20.2%) | -$58.53 M(+50.3%) |
| Mar 2015 | - | -$14.84 M(+14.9%) | -$38.94 M(+559.3%) |
| Dec 2014 | -$5.91 M(-85.1%) | -$12.91 M(-0.2%) | -$5.91 M(+70.4%) |
| Sept 2014 | - | -$12.94 M(-839.0%) | -$3.46 M(-6637.7%) |
| June 2014 | - | $1.75 M(-90.4%) | $53.00 K(-100.4%) |
| Mar 2014 | - | $18.19 M(-273.8%) | -$12.74 M(-68.0%) |
| Dec 2013 | -$39.77 M(-2.9%) | -$10.47 M(+11.1%) | -$39.77 M(-3.8%) |
| Sept 2013 | - | -$9.42 M(-14.7%) | -$41.35 M(+2.1%) |
| June 2013 | - | -$11.04 M(+25.1%) | -$40.52 M(+3.7%) |
| Mar 2013 | - | -$8.83 M(-26.8%) | -$39.07 M(-4.6%) |
| Dec 2012 | -$40.94 M(+41.9%) | -$12.06 M(+40.4%) | -$40.94 M(+41.7%) |
| Sept 2012 | - | -$8.59 M(-10.5%) | -$28.88 M(+42.3%) |
| June 2012 | - | -$9.60 M(-10.3%) | -$20.29 M(+89.7%) |
| Mar 2012 | - | -$10.70 M | -$10.70 M |
| Dec 2011 | -$28.85 M(+141.0%) | - | - |
| Dec 2010 | -$11.97 M | - | - |
FAQ
- What is Prothena annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Prothena?
- What is Prothena quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Prothena?
- What is Prothena quarterly EBITDA year-on-year change?
- What is Prothena TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Prothena?
- What is Prothena TTM EBITDA year-on-year change?
What is Prothena annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PRTA is -$191.04 M
What is the all time high annual EBITDA for Prothena?
Prothena all-time high annual earnings before interest, taxes, depreciation & amortization is $73.09 M
What is Prothena quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PRTA is -$66.29 M
What is the all time high quarterly EBITDA for Prothena?
Prothena all-time high quarterly earnings before interest, taxes, depreciation & amortization is $110.94 M
What is Prothena quarterly EBITDA year-on-year change?
Over the past year, PRTA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$11.95 M (+15.28%)
What is Prothena TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PRTA is -$167.23 M
What is the all time high TTM EBITDA for Prothena?
Prothena all-time high TTM earnings before interest, taxes, depreciation & amortization is $79.88 M
What is Prothena TTM EBITDA year-on-year change?
Over the past year, PRTA TTM earnings before interest, taxes, depreciation & amortization has changed by +$22.88 M (+12.03%)